MOSTI, LUISA
 Distribuzione geografica
Continente #
EU - Europa 8.743
AS - Asia 924
NA - Nord America 342
SA - Sud America 78
AF - Africa 12
OC - Oceania 2
Totale 10.101
Nazione #
IT - Italia 8.601
SG - Singapore 434
US - Stati Uniti d'America 330
CN - Cina 227
VN - Vietnam 158
FR - Francia 66
BR - Brasile 54
HK - Hong Kong 37
DE - Germania 19
AR - Argentina 18
FI - Finlandia 14
GB - Regno Unito 12
IN - India 12
JP - Giappone 11
CH - Svizzera 10
BD - Bangladesh 6
ID - Indonesia 6
MX - Messico 6
ZA - Sudafrica 6
RU - Federazione Russa 5
CA - Canada 4
IQ - Iraq 4
KH - Cambogia 4
PH - Filippine 4
EC - Ecuador 3
JO - Giordania 3
TR - Turchia 3
AU - Australia 2
ES - Italia 2
IE - Irlanda 2
KR - Corea 2
NL - Olanda 2
TH - Thailandia 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KW - Kuwait 1
NG - Nigeria 1
NP - Nepal 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UA - Ucraina 1
VE - Venezuela 1
Totale 10.101
Città #
Genova 5.535
Genoa 1.886
Rapallo 602
Vado Ligure 541
Singapore 243
San Jose 173
Lauterbourg 63
Ho Chi Minh City 45
Hanoi 38
Hong Kong 36
Ashburn 34
New York 27
Beijing 21
Santa Clara 18
Frankfurt am Main 16
Helsinki 13
Tokyo 11
Zurich 10
Milan 8
Bordighera 7
Da Nang 7
Haiphong 7
Tianjin 7
Mexico City 6
Cardiff 5
Los Angeles 5
Naples 5
São Paulo 5
Atlanta 4
Buenos Aires 4
Chicago 4
Johannesburg 4
Mumbai 4
Phnom Penh 4
Bengaluru 3
Can Tho 3
Denver 3
Des Moines 3
Nha Trang 3
Orem 3
Rome 3
Wuhan 3
Amman 2
Amsterdam 2
Baghdad 2
Belo Horizonte 2
Biên Hòa 2
City of London 2
Curitiba 2
Córdoba 2
Davao City 2
Dublin 2
Jakarta 2
Montreal 2
Rio de Janeiro 2
Tashkent 2
Thái Nguyên 2
Zhengzhou 2
Agua de Oro 1
Alcira Gigena 1
Arroyito 1
Aryanah 1
As Sālimīyah 1
Bagé 1
Baku 1
Bandar Seri Begawan 1
Barquisimeto 1
Barra Mansa 1
Barra do Piraí 1
Batna City 1
Bauru 1
Bijeljina 1
Brandon 1
Bratislava 1
Brejo do Cruz 1
Brescia 1
Bridgetown 1
Brisbane 1
Brooklyn 1
Brussels 1
Budapest 1
Buffalo 1
Bursa 1
Bình Dương 1
Bình Phước 1
Bắc Ninh 1
Cairo 1
Campo Grande 1
Campos dos Goytacazes 1
Cao Lanh 1
Cataguases 1
Caxias do Sul 1
Cedral 1
Cerro Azul 1
Cesena 1
Chapecó 1
Chengdu 1
Chennai 1
Cixi 1
Concordia 1
Totale 9.496
Nome #
An efficient synthesis of functionalized 2-pyridones by direct route or via amide/enolate ammonium salt intermediates 209
1-Phenyl-1H-Indazole derivatives with analgesic and anti-inflammatory activities. 208
Chemometric study and validation strategies in the structure-activity relationships of new cardiotonic agents 205
4-Dialkylamino-1-(5-substituted or unsubstituted 1-phenyl-1H-pyrazol-4-yl)butan-1-ols: synthesis and evaluation of analgesic, anti-inflammatory and platelet anti-aggregating activities 191
3-Acetyl-5-acylpyridin-2(1H)-ones and 3-acetyl-7,8-dihydro-2,5(1H,6H)-quinolinediones: synthesis, cardiotonic activity and computational studies 188
CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists. 186
Affinity prediction on A1 adenosine receptor agonists: the chemometric approach 186
Exploring the QSAR of pyrazolo[3,4-b]pyridine, pyrazolo[3,4-b]pyridone and pyrazolo[3,4-b]pyrimidine derivatives as antagonists for A1 adenosine receptor. 179
Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors 178
A chemometric approach to predict A1 agonist effect of adenosine analogues 171
2- substituted 5-acetyl-1,6-dihydro-6-oxo-3-pyridinecarboxylates: synthesis and cardiotonic activity 165
4-Substituted 1,5-diarylpyrazoles, analogues of celecoxib: synthesis and preliminary evaluation of biological properties 162
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 161
Structural basis for selective PDE 3 inhibition: a docking study 159
4-Substituted 1-methyl-1H-indazoles with analgesic, antiinflammatory and antipyretic activities 158
CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists 155
Synthesis of 5-substituted 1-aryl-1H-pyrazole-4-acetonitriles, 4-methyl-1-phenyl-1H-pyrazole-3-carbonitrile and pharmacologically active 1-aryl-1H-pyrazole-4-acetic acids. 153
Synthesis and preliminary biological evaluation of novel N-substituted 1-amino-3-[1-methyl(phenyl)-1H-indazol-4-yloxy]-propan-2-ols interesting as potential antiarrhythmic, local anaesthetic and analgesic agents 153
A New Milrinone analog: Role of Binding to A1 Adenosine Receptor in its Positive Inotropic Effect on Isolated Guinea Pig and Rat Atria 153
Synthesis and Cardiotonic Activity of Novel Pyrimidine Derivatives. Crystallographic and Quantum Chemical Studies 150
An updated topographical model for phosphodiesterase 4 (PDE4) catalytic site 147
Synthesis, molecular modeling studies and pharmacological activity of selective A1 receptor antagonists 146
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 144
2-Pyridone derivatives as inotropic agents: synthesis, pharmacology and molecular modeling study 142
Unprecedented one-pot stereoselective synthesis of Knoevenagel-type derivatives via in situ condensation of N-methyleniminium salts of ethylenethiourea and ethyleneurea with active methylene reagents 140
Exploring the molecular basis of selectivity in A1 adenosine receptors antagonist: a case study 138
Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and QSAR analysis 137
New halogenated 4-aminopyrazolo[3,4-b]pyridines A1 adenosine receptor ligands 136
Novel angular furo and thieno-quinolinones: synthesis and preliminary photobiological studies 135
Structure-based Design, Parallel Synthesis, SAR and Molecular Modelling Studies of Thiocarbamates, New Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor Isosteres of Phenethylthiazolylthiourea Derivatives. 134
DNA-psoralens molecular recognition using molecular dynamics 134
Ionization Behaviour and Tautomerism-Dependent Lipophilicity of Pyridine-2(1H)-one Cardiotonic Agents 133
Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model. 131
Synthesis of indole imminun salts as key-intermediates in a convergent multi-step one-pot stereoselective synthesis of new potent antiproliferative Knoevenagel-type agent 130
Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site 130
Synthesis and Pharmacological Characterization of Functionalized 2-Pyridones Structurally Related to the Cardiotonic Agent Milrinone 130
Zups: the evolution of a new class of molecular descriptors 128
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 128
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells 127
Synthesis of 1-(2-chloro-2-phenylethyl)-6-methylthio-1-H-pyrazolo[3,4-d]pyrimidines 4-amino substituted and their biological evaluation 126
Insights into Structure-Activity Relationships from Lipophilicity Profiles of Pyridin-2(1H)-one Analogs of the Cardiotonic Agent Milrinone 126
2-Pyridone derivatives as inotropic agents: synthesis, pharmacology and molecular modeling study 126
Development of a new topographical model for myocardial cGI-PDE catalytic site 120
New pyrazolo[3,4-b]pyridones as selective A1 adenosine receptor antagonists: synthesis, biological evaluation and molecular modeling studies 119
Synthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands 119
Quinolinedione nucleus as a novel scaffold for A1 and A2A adenosine receptor antagonists. 118
null 117
Towards the identification of the cardiac cAMP phosphodiesterase receptor site 116
Modulazioni Strutturali in O-[2-(N-Ftalimmido)etil] Acil(Aril)Tiocarbammati, Inibitori Non-Nucleosidici della Transcrittasi Inversa di HIV-1 116
Toward the identification of the cardiac cGMP inhibited-phosphodiesterase catalytic site 116
null 116
Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and 3D-QSAR analysis 113
Reaction of Sulfene with Heterocyclic N, N-Disubstituted alfa-Amino methyleneketones. IX. Synthesis of 1,2-Oxathiino [6,5-e] indole Derivatives. 113
New milrinone analogues:in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine and inhibition of cardiac type III phosphodiesterase 112
Synthesis and biological evaluation of azole derivatives, analogues of bifonazole, with a phenylisoxazolyl or phenylpyrimidinyl moiety 111
Synthesis of pyrazolo[3,4-d]pyridines selective antagonists of A1 adenosine receptors 110
Reaction of Sulfene with Heterocyclic N,N-Disubstituted alfa-Amino methyleneketones.XI. Synthesis of 1,2-Oxathiino[5,6-d]-1-benzoxepin Derivatives. 110
Molecular Modeling of DNA-psoralens complexes 109
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines 109
Androstane derivatives: synthesis of substituted 6'-H-androst-2-eno*3,2-b*pyran-6'-ones. 107
In silico rationalization of the structural and physicochemical requirements for photobiological activity in angelicine derivatives and their heteroanalogues 106
QSAR study on new cardiotonic agents related to milrinone 103
Riconoscimento molecolare DNA-psoraleni mediante tecniche di dinamica molecolare 103
Synthesis, antimicrobial activity and molecular modelling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazoles 99
null 99
Flavonoidverbindungen und Allantoin aus Anchusa officinalis L. 97
Synthesis, Biological Evaluation and Molecular Modeling Studies on Benzothiadiazine Derivatives as PDE4 Selective Inhibitors 95
null 95
New pyrazolo[3,4-b]pyridines antagonist of A1 adenosine receptors 93
Glycoside und Depside aus den Blättern von Castanea sativa Mill. 90
omega-Dialkylaminoalkil Ethers of Phenyl-(5-substituted 1-phenyl-1H-pyrazol-4-yl)methanols with Analgesic and Anti-inflammatory Activity 88
Inotropic Agents. Synthesis and Structure-Activity Relationships of New Milrinone Related cAMP PDEIII inhibitors 88
Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitors 87
Synthesis and photobiological properties of 3-acylangelicins, 3-alkoxycarbonyl-angelicins and related derivatives 83
Studio computazionale di complessi di intercalazione al buio DNA-psoraleni Pavia, 27-29 maggio 1999 81
Zupan's descriptors in QSAR applied to the study of a new class of cardiotonic agents 81
Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses 76
Synthesis of new pyrazolo[3,4-b]pyridines: new selective A1 adenosine receptor antagonists 73
Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses 35
Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabant 33
Synthesis of N-substituted-N-acylthioureas of 4-substituted piperazines endowed with local anaesthetic, antihyperlipidemic, antiproliferative activities and antiarrythmic, analgesic, antiaggregating actions 24
Totale 10.198
Categoria #
all - tutte 29.614
article - articoli 24.422
book - libri 0
conference - conferenze 5.192
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 38 26 43
2021/2022949 43 85 70 91 26 43 63 254 39 85 45 105
2022/2023730 66 47 7 85 122 121 0 37 104 5 117 19
2023/2024361 20 59 11 51 38 51 20 15 9 12 35 40
2024/20251.322 24 91 40 105 189 130 99 248 72 62 131 131
2025/20262.170 285 58 167 194 363 231 428 111 134 199 0 0
Totale 10.198